ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Cutting-Edge Antibody Validation Service by Boster Bio Set to Enhance Research Accuracy

By: Get News
Cutting-Edge Antibody Validation Service by Boster Bio Set to Enhance Research Accuracy
Boster Bio advances biomedical research with rigorously validated antibodies and expert IHC services, ensuring reproducibility for scientists worldwide.

Boster Biological Technology (Boster Bio), a leading provider of antibody and immunoassay solutions, is revolutionizing biomedical research with its antibody validation service and IHC services. These offerings ensure researchers receive rigorously tested, high-quality reagents, addressing a critical need for reproducibility in scientific studies.

A major challenge in life sciences research is the inconsistent performance of antibodies, which can lead to unreliable data. Boster Bio’s antibody validation service tackles this issue head-on by employing a multi-step verification process. Each antibody undergoes specificity, sensitivity, and reproducibility testing across multiple applications, including Western blot, ELISA, and immunohistochemistry (IHC).

What sets Boster Bio apart is its commitment to transparency. Researchers receive comprehensive validation reports, including detailed experimental conditions and raw data. This level of scrutiny ensures that antibodies perform as expected, reducing wasted time and resources. A unique industry advantage, the company also offers a free validation for the PicoBand antibodies promotion, allowing scientists to test antibodies before purchase.

In addition to antibody validation, Boster Bio offers specialized IHC services, catering to researchers who require high-quality immunohistochemistry without needing in-house optimization. The company’s histology experts handle everything from tissue sectioning to staining, using validated protocols to deliver consistent, publication-ready results.

Boster Bio’s IHC services stand out due to their customization options. Researchers can request specific antibodies, staining techniques, or tissue types, ensuring tailored solutions for unique projects. The team also offers troubleshooting support, a critical resource for complex studies.

With increasing scrutiny on research reproducibility, Boster Bio’s emphasis on validation and quality control fills a crucial gap. Besides the free antibody validation for select products, the company provides comprehensive IHC services with expert support, including transparent reporting and their accompanying raw data.

For more information, visit https://www.bosterbio.com/

A leading antibody manufacturer since 1993, Boster Bio combines scientific excellence and customer-focused solutions. Dedicated to advancing biomedical research, the company delivers rigorously validated reagents and expert support to scientists worldwide. This empowers researchers to achieve accurate, reproducible results that can accelerate discoveries in immunology, oncology, and neuroscience.

The service to validate antibodies for IHC, WB, ELISA, IF/ICC, or flow cytometry experiments is crucial in today’s fast-developing biotech sector. Boster Bio's experts accelerate research efforts by providing over 200 ready-to-use control samples available for validation.

Whether validating antibodies generated in-house or procured commercially, the validation process can be time-consuming, expensive, and frustrating. As an antibody manufacturer, Boster Bio addresses this issue by leveraging its economies of scale and close relationships with other antibody companies.

With fast turnaround empowered by scale and expertise, the company readily accommodates custom requirements cost-effectively and efficiently. Additionally, Boster Bio assigns a dedicated project manager from start to finish.

The company also offers a large selection of ready-to-use cell lines and tissue lysates for your assay controls. Compared to acquiring these in-house, using commercially available lysates could save months of cell culture work and related expenses.

Boster Biological Technology is a leading provider of high-quality antibodies, ELISA kits, and custom assay services. Specializing in antibody validation and IHC services, the company ensures research accuracy with stringent quality controls and transparent reporting. Based in Pleasanton, CA, Boster Bio supports scientists in immunology, oncology, and neuroscience with reliable reagents and expert technical assistance. Its unique offerings, including free antibody validation and tailored immunohistochemistry solutions, set it apart in the competitive life sciences market. Committed to accelerating discoveries, Boster Bio empowers researchers with trusted tools for reproducible, publication-ready results.

About the Company:

Boster Bio is a leading manufacturer of antibodies and ELISA kits critical to advancing life science research. Specializing in custom monoclonal antibody production services and offering free antibody validation, the company supports researchers with high-quality reagents and exceptional service. Based in Pleasanton, CA, Boster Bio continues to innovate in antibody development and immunoassay solutions.

Media Contact
Company Name: Boster Biological Technology
Contact Person: CJ Xia
Email: Send Email
Phone: (888) 466-3604
Address:3942 Valley Ave
City: Pleasanton
State: CA 94566
Country: United States
Website: https://www.bosterbio.com/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.